Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPO
2151
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $3.92M | ﹤0.01% |
33,694
+814
| +2% | +$94.3K |
|
2152
MGP Ingredients
MGPI
$389M
| $3.91M | ﹤0.01% |
80,741
+1,485
| +2% | +$69.5K |
|
2153
National Beverage
FIZZ
$2.93B
| $3.91M | ﹤0.01% |
153,136
+2,778
| +2% | +$66.8K |
|
2154
Palomar
PLMR
$3.37B
| $3.9M | ﹤0.01% |
77,195
+42,977
| +126% | +$2.01M |
|
2155
iHeartMedia
IHRT
$464M
| $3.89M | ﹤0.01% |
230,149
+5,061
| +2% | +$76.7K |
|
|
INXN
2156
DELISTED
Interxion Holding N.V.
INXN
| $3.89M | ﹤0.01% |
46,376
-1,068
| -2% | -$89.2K |
|
|
BFS
2157
Saul Centers
BFS
$865M
| $3.88M | ﹤0.01% |
73,515
+2,156
| +3% | +$114K |
|
2158
OneSpaWorld
OSW
$2.73B
| $3.87M | ﹤0.01% |
229,657
+4,194
| +2% | +$66K |
|
2159
Constellium
CSTM
$3.95B
| $3.85M | ﹤0.01% |
287,558
-13,414
| -4% | -$185K |
|
2160
Axogen
AXGN
$2.58B
| $3.84M | ﹤0.01% |
214,683
+4,576
| +2% | +$67.6K |
|
|
SPWR
2161
DELISTED
SunPower Corporation Common Stock
SPWR
| $3.83M | ﹤0.01% |
749,989
+170,401
| +29% | +$947K |
|
|
TSC
2162
DELISTED
TriState Capital Holdings, Inc.
TSC
| $3.83M | ﹤0.01% |
146,618
+2,300
| +2% | +$54.8K |
|
2163
1-800-Flowers.com
FLWS
$261M
| $3.82M | ﹤0.01% |
263,689
+3,490
| +1% | +$47.4K |
|
2164
Copa Holdings
CPA
$6.17B
| $3.82M | ﹤0.01% |
35,302
-29,773
| -46% | -$3.11M |
|
|
EFC
2165
Ellington Financial
EFC
$1.76B
| $3.81M | ﹤0.01% |
208,087
+17,756
| +9% | +$324K |
|
2166
NextCure
NXTC
$37.9M
| $3.81M | ﹤0.01% |
5,642
+3,322
| +143% | +$1.67M |
|
|
THOR
2167
DELISTED
Synthorx, Inc. Common Stock
THOR
| $3.81M | ﹤0.01% |
54,488
+2,718
| +5% | +$77.6K |
|
2168
Cytokinetics
CYTK
$10.2B
| $3.8M | ﹤0.01% |
358,522
+6,501
| +2% | +$66.8K |
|
2169
Gossamer Bio
GOSS
$83.3M
| $3.8M | ﹤0.01% |
242,808
+4,154
| +2% | +$83.7K |
|
|
ADVM
2170
DELISTED
Adverum Biotechnologies
ADVM
| $3.79M | ﹤0.01% |
32,938
+778
| +2% | +$68.6K |
|
2171
Prothena Corp
PRTA
$466M
| $3.78M | ﹤0.01% |
239,006
+5,390
| +2% | +$57.8K |
|
2172
Hanmi Financial
HAFC
$963M
| $3.77M | ﹤0.01% |
188,558
+4,882
| +3% | +$94.2K |
|
2173
Midland States Bancorp
MSBI
$698M
| $3.76M | ﹤0.01% |
129,817
+2,413
| +2% | +$66.4K |
|
|
APTS
2174
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $3.76M | ﹤0.01% |
282,169
+8,252
| +3% | +$114K |
|
|
HSII
2175
DELISTED
Heidrick & Struggles
HSII
| $3.75M | ﹤0.01% |
115,245
-28,245
| -20% | -$832K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.